Cargando…
Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
Endocan is a vascular endothelium-derived factor regulated by angiogenic factors. The aim of this study was to determine whether serum endocan levels are prognostic for survival in patients with hepatocellular carcinoma (HCC). Serum endocan levels were measured in 64 HCC patients who were naïve to t...
Autores principales: | Ozaki, Kazuaki, Toshikuni, Nobuyuki, George, Joseph, Minato, Takahiro, Matsue, Yasuhiro, Arisawa, Tomiyasu, Tsutsumi, Mikihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963079/ https://www.ncbi.nlm.nih.gov/pubmed/24665346 http://dx.doi.org/10.7150/jca.7691 |
Ejemplares similares
-
Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013) -
Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection
por: Matsue, Yasuhiro, et al.
Publicado: (2015) -
An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017) -
Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017) -
Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)